This narrative review discusses how forming inclusion complexes with cyclodextrins is a tool to improve the oral bioavailability and stability of various drugs and nutraceuticals.
Pharmaceutics · 5 authors, 2 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This narrative review discusses how forming inclusion complexes with cyclodextrins is a tool to improve the oral bioavailability and stability of various drugs and nutraceuticals.
This is a narrative review covering synthetic, analytical, and pharmaceutical aspects of cyclodextrin inclusion complexes. It describes how cyclodextrins, as cyclic oligosaccharides, can form complexes with active pharmaceutical ingredients and nutraceuticals to improve properties like dissolution rate, bioavailability, and stability. The review discusses the use of cyclodextrin-based polymers, nanosponges, and nanofibers for drug delivery and stabilization, with examples for labile drugs and poorly soluble compounds classified as BCS class IV. It also reviews synthetic routes for chemically modified cyclodextrins and analytical techniques (e.g., spectroscopic methods) to verify complex formation in solution and solid state. The review concludes that cyclodextrins and their derivatives offer possibilities for personalized medicine and sustained drug delivery.